These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22991414)

  • 21. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.
    Brody JR; Costantino CL; Potoczek M; Cozzitorto J; McCue P; Yeo CJ; Hruban RH; Witkiewicz AK
    Mod Pathol; 2009 May; 22(5):651-9. PubMed ID: 19270646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatic mutations in exocrine pancreatic tumors: association with patient survival.
    Rachakonda PS; Bauer AS; Xie H; Campa D; Rizzato C; Canzian F; Beghelli S; Greenhalf W; Costello E; Schanne M; Heller A; Scarpa A; Neoptolemos JP; Werner J; Büchler M; Hoheisel JD; Hemminki K; Giese N; Kumar R
    PLoS One; 2013; 8(4):e60870. PubMed ID: 23565280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes.
    Schlitter AM; Segler A; Steiger K; Michalski CW; Jäger C; Konukiewitz B; Pfarr N; Endris V; Bettstetter M; Kong B; Regel I; Kleeff J; Klöppel G; Esposito I
    Sci Rep; 2017 Feb; 7():41064. PubMed ID: 28145465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.
    Embuscado EE; Laheru D; Ricci F; Yun KJ; de Boom Witzel S; Seigel A; Flickinger K; Hidalgo M; Bova GS; Iacobuzio-Donahue CA
    Cancer Biol Ther; 2005 May; 4(5):548-54. PubMed ID: 15846069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.
    Huang J; Löhr JM; Nilsson M; Segersvärd R; Matsson H; Verbeke C; Heuchel R; Kere J; Iafrate AJ; Zheng Z; Ye W
    Clin Chem; 2015 Nov; 61(11):1408-16. PubMed ID: 26378065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.
    Barrett MT; Deiotte R; Lenkiewicz E; Malasi S; Holley T; Evers L; Posner RG; Jones T; Han H; Sausen M; Velculescu VE; Drebin J; O'Dwyer P; Jameson G; Ramanathan RK; Von Hoff DD
    Br J Cancer; 2017 Aug; 117(4):572-582. PubMed ID: 28720843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic sequencing of key genes in mouse pancreatic cancer cells.
    Wang Y; Zhang Y; Yang J; Ni X; Liu S; Li Z; Hodges SE; Fisher WE; Brunicardi FC; Gibbs RA; Gingras MC; Li M
    Curr Mol Med; 2012 Mar; 12(3):331-41. PubMed ID: 22208613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern.
    Sanchez P; Espinosa M; Maldonado V; Barquera R; Belem-Gabiño N; Torres J; Cravioto A; Melendez-Zajgla J
    Mol Biol Rep; 2020 Jul; 47(7):5175-5184. PubMed ID: 32583281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution and dynamics of pancreatic cancer progression.
    Yachida S; Iacobuzio-Donahue CA
    Oncogene; 2013 Nov; 32(45):5253-60. PubMed ID: 23416985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.
    Kanda M; Matthaei H; Wu J; Hong SM; Yu J; Borges M; Hruban RH; Maitra A; Kinzler K; Vogelstein B; Goggins M
    Gastroenterology; 2012 Apr; 142(4):730-733.e9. PubMed ID: 22226782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9.
    Ono M; Ono Y; Nakamura T; Tsuchikawa T; Kuraya T; Kuwabara S; Nakanishi Y; Asano T; Matsui A; Tanaka K; Ebihara Y; Kurashima Y; Noji T; Murakami S; Shichinohe T; Mitsuhashi T; Omori Y; Furukawa T; Taniue K; Suzuki M; Sugitani A; Karasaki H; Mizukami Y; Hirano S
    Ann Surg Oncol; 2022 Aug; 29(8):5007-5019. PubMed ID: 35399143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
    Dunne RF; Hezel AF
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational research in pancreatic cancer: KRAS and beyond.
    Boeck S; Ormanns S; Haas M; Bächmann S; Laubender RP; Siveke JT; Jung A; Kirchner T; Heinemann V
    Pancreas; 2014 Jan; 43(1):150-2. PubMed ID: 24326376
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenotype and genotype of pancreatic cancer cell lines.
    Deer EL; González-Hernández J; Coursen JD; Shea JE; Ngatia J; Scaife CL; Firpo MA; Mulvihill SJ
    Pancreas; 2010 May; 39(4):425-35. PubMed ID: 20418756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.
    Kuboki Y; Shimizu K; Hatori T; Yamamoto M; Shibata N; Shiratori K; Furukawa T
    Pancreas; 2015 Mar; 44(2):227-35. PubMed ID: 25423558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients.
    Paiella S; Malleo G; Cataldo I; Gasparini C; De Pastena M; De Marchi G; Marchegiani G; Rusev B; Scarpa A; Girelli R; Giardino A; Frigerio I; D'Onofrio M; Secchettin E; Bassi C; Salvia R
    Langenbecks Arch Surg; 2018 Mar; 403(2):213-220. PubMed ID: 28983662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and epigenetic alterations of familial pancreatic cancers.
    Brune K; Hong SM; Li A; Yachida S; Abe T; Griffith M; Yang D; Omura N; Eshleman J; Canto M; Schulick R; Klein AP; Hruban RH; Iacobuzio-Donohue C; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3536-42. PubMed ID: 19064568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications.
    Hu HF; Ye Z; Qin Y; Xu XW; Yu XJ; Zhuo QF; Ji SR
    Acta Pharmacol Sin; 2021 Nov; 42(11):1725-1741. PubMed ID: 33574569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characteristics of early-onset pancreatic ductal adenocarcinoma.
    Debernardi S; Liszka L; Ntala C; Steiger K; Esposito I; Carlotti E; Baker AM; McDonald S; Graham T; Dmitrovic B; Feakins RM; Crnogorac-Jurcevic T
    Mol Oncol; 2024 Mar; 18(3):677-690. PubMed ID: 38145461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.